Salim Hayek to Receptors, Urokinase Plasminogen Activator
This is a "connection" page, showing publications Salim Hayek has written about Receptors, Urokinase Plasminogen Activator.
Connection Strength
2.046
-
Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein. J Am Heart Assoc. 2018 05 01; 7(9).
Score: 0.590
-
A tripartite complex of suPAR, APOL1 risk variants and avĂ3 integrin on podocytes mediates chronic kidney disease. Nat Med. 2017 Aug; 23(8):945-953.
Score: 0.557
-
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI. J Am Soc Nephrol. 2020 11; 31(11):2725-2735.
Score: 0.174
-
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Crit Care. 2020 04 30; 24(1):187.
Score: 0.169
-
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children. JAMA Pediatr. 2017 11 06; 171(11):e172914.
Score: 0.143
-
Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes. Atherosclerosis. 2017 Sep; 264:108-114.
Score: 0.139
-
Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis. Clin J Am Soc Nephrol. 2017 Aug 07; 12(8):1265-1273.
Score: 0.138
-
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death. Circ Cardiovasc Qual Outcomes. 2017 03; 10(3).
Score: 0.136